TrialEuropean urology2023

Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695).

Thomas W Flaig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.